Discovery of Potent Disheveled/Dvl Inhibitors Using Virtual Screening Optimized With NMR-Based Docking Performance Index
Authors:
Open Access
- 5 September 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 9, 983
Abstract
Most solid tumors have their own cancer stem cells (CSCs), which are resistant to standard chemo-therapies. Recent reports have described that Wnt pathway plays a key role in self-renewal and tumorigenesis of CSCs. Regarding the Wnt/β-catenin pathway, Dvl (mammalian Disheveled) is an attractive target of drug discovery. After analyzing the PDZ domain of human Dvl1 (Dvl1-PDZ) using NMR, we subjected it to preliminary NMR titration studies with 17 potential PDZ-binding molecules including CalBioChem-322338, a commercially available Dvl PDZ domain inhibitor. Next, we performed virtual screening (VS) using the program GOLD with nine parameter sets. Results were evaluated using the NMR-derived docking performance index (NMR-DPI). One parameter set of GOLD docking showing the best NMR-DPI was selected and used for the second VS against 5,135 compounds. The second docking trial identified more than 1,700 compounds that exhibited higher scores than CalBioChem-322338. Subsequent NMR titration experiments with five new candidate molecules (NPL-4001, 4004, 4011, 4012, and 4013), Dvl1-PDZ revealed larger chemical shift changes than those of CalBioChem-322338. Finally, these compounds showed partial proliferation inhibition activity against BT-20, a triple negative breast cancer (TNBC) cell. These compounds are promising Wnt pathway inhibitors that are potentially useful for anti-TNBC therapy.Keywords
Funding Information
- Japan Science and Technology Agency (Target Protein Research Program, A-step feasibility study program AS242Z00566Q, A-step feasibility study program AS262Z01275Q)
- Japan Society for the Promotion of Science (KAKENHI 15H04337)
- Princess Takamatsu Cancer Research Fund (15-24726)
This publication has 44 references indexed in Scilit:
- Drugging Wnt signalling in cancerThe EMBO Journal, 2012
- Frizzled7 as an emerging target for cancer therapyCellular Signalling, 2012
- SAHG, a comprehensive database of predicted structures of all human proteinsNucleic Acids Research, 2010
- Sulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein DishevelledAngewandte Chemie International Edition, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of DishevelledJournal of Biological Chemistry, 2009
- Identification of tripeptides recognized by the PDZ domain of DishevelledBioorganic & Medicinal Chemistry, 2009
- eF-seek: prediction of the functional sites of proteins by searching for similar electrostatic potential and molecular surface shapeNucleic Acids Research, 2007
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995